Search research articles
Contact Us
Filters
Showing results (461-470 of 475) with videos related to
Page
of 48
Sort By:
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
August 9, 2020
Impact of COVID-19 pandemic on STEMI care: An expanded analysis from the United States
Santiago Garcia, Larissa Stanberry, Christian Schmidt, et al.
Lancet (London, England)
|
June 18, 2016
Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network
Olivier Hermine, Eva Hoster, Jan Walewski, et al.
Lancet (London, England)
|
May 5, 2024
Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE): a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma Network
Martin Dreyling, Jeanette Doorduijn, Eva Giné, et al.
Resuscitation
|
May 1, 2022
Effect of vasopressin and methylprednisolone vs. placebo on long-term outcomes in patients with in-hospital cardiac arrest a randomized clinical trial
Asger Granfeldt, Birthe Sindberg, Dan Isbye, et al.
JAMA
|
September 29, 2021
Effect of Vasopressin and Methylprednisolone vs Placebo on Return of Spontaneous Circulation in Patients With In-Hospital Cardiac Arrest: A Randomized Clinical Trial
Lars W Andersen, Dan Isbye, Jesper Kjærgaard, et al.
Lancet (London, England)
|
May 14, 2026
Addition of autologous stem-cell transplantation to an ibrutinib-containing first-line treatment in patients aged 18-65 years with mantle cell lymphoma (TRIANGLE): 4·5-year follow-up of a three-arm, randomised, open-label, phase 3 superiority trial of the European MCL Network
Martin Dreyling, Jeanette Doorduijn, Eva Giné, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 14, 2026
Rituximab Maintenance Added to Ibrutinib-Containing Therapy in Younger, Untreated Patients With Mantle Cell Lymphoma: Results From the TRIANGLE Trial
Marco Ladetto, Katja Gutmair, Rita Tavarozzi, et al.
European Heart Journal
|
January 9, 2022
Multi-organ assessment in mainly non-hospitalized individuals after SARS-CoV-2 infection: The Hamburg City Health Study COVID programme
Elina Larissa Petersen, Alina Goßling, Gerhard Adam, et al.
Nature Metabolism
|
March 29, 2022
Molecular consequences of SARS-CoV-2 liver tropism
Nicola Wanner, Geoffroy Andrieux, Pau Badia-I-Mompel, et al.
Lancet (London, England)
|
December 24, 2019
Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial
Viola Poeschel, Gerhard Held, Marita Ziepert, et al.
Page
of 48
Search research articles
Search
Showing results (461-470 of 475) with videos related to
Sort By:
Page
of 48
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
August 9, 2020
Impact of COVID-19 pandemic on STEMI care: An expanded analysis from the United States
Santiago Garcia, Larissa Stanberry, Christian Schmidt, et al.
Lancet (London, England)
|
June 18, 2016
Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network
Olivier Hermine, Eva Hoster, Jan Walewski, et al.
Lancet (London, England)
|
May 5, 2024
Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE): a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma Network
Martin Dreyling, Jeanette Doorduijn, Eva Giné, et al.
Resuscitation
|
May 1, 2022
Effect of vasopressin and methylprednisolone vs. placebo on long-term outcomes in patients with in-hospital cardiac arrest a randomized clinical trial
Asger Granfeldt, Birthe Sindberg, Dan Isbye, et al.
JAMA
|
September 29, 2021
Effect of Vasopressin and Methylprednisolone vs Placebo on Return of Spontaneous Circulation in Patients With In-Hospital Cardiac Arrest: A Randomized Clinical Trial
Lars W Andersen, Dan Isbye, Jesper Kjærgaard, et al.
Lancet (London, England)
|
May 14, 2026
Addition of autologous stem-cell transplantation to an ibrutinib-containing first-line treatment in patients aged 18-65 years with mantle cell lymphoma (TRIANGLE): 4·5-year follow-up of a three-arm, randomised, open-label, phase 3 superiority trial of the European MCL Network
Martin Dreyling, Jeanette Doorduijn, Eva Giné, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 14, 2026
Rituximab Maintenance Added to Ibrutinib-Containing Therapy in Younger, Untreated Patients With Mantle Cell Lymphoma: Results From the TRIANGLE Trial
Marco Ladetto, Katja Gutmair, Rita Tavarozzi, et al.
European Heart Journal
|
January 9, 2022
Multi-organ assessment in mainly non-hospitalized individuals after SARS-CoV-2 infection: The Hamburg City Health Study COVID programme
Elina Larissa Petersen, Alina Goßling, Gerhard Adam, et al.
Nature Metabolism
|
March 29, 2022
Molecular consequences of SARS-CoV-2 liver tropism
Nicola Wanner, Geoffroy Andrieux, Pau Badia-I-Mompel, et al.
Lancet (London, England)
|
December 24, 2019
Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial
Viola Poeschel, Gerhard Held, Marita Ziepert, et al.
Page
of 48